Powerhouse down: Complex II dissociation in the respiratory chain

Mitochondrion

Volumn 19, Issue Part A, 2014, Pages 20-28

  Hwang, Ming Shih ^a   Rohlena, Jakub ^b   Dong, Lan Feng ^c   Neuzil, Jiri ^b,c   Grimm, Stefan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Apoptosis; Complex II; Mitochondria

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; NATURAL PRODUCT; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE (UBIQUINONE); MULTIENZYME COMPLEX;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CANCER CELL; CARCINOGENESIS; DRUG MECHANISM; ENZYME STRUCTURE; HUMAN; MUTATION; NONHUMAN; OXIDATIVE STRESS; PH; PROTEIN FUNCTION; RESPIRATORY CHAIN; ANIMAL; CELL DEATH; ENERGY METABOLISM; GENE EXPRESSION REGULATION; MITOCHONDRION; PHYSIOLOGY;

ANIMALS; CELL DEATH; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; MITOCHONDRIA;

EID: 84911403189     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2014.06.001     Document Type: Article

References (122)

1. Albayrak T., Grimm S. A high-throughput screen for single gene activities: isolation of apoptosis inducers. Biochem. Biophys. Res. Commun. 2003, 304:772-776.
2. Albayrak T., Scherhammer V., Schoenfeld N., Braziulis E., Mund T., Bauer M.K., Scheffler I.E., Grimm S. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol. Biol. Cell 2003, 14:3082-3096.
3. Amar L., Bertherat J., Baudin E., Ajzenberg C., Bressac-de Paillerets B., Chabre O., Chamontin B., Delemer B., Giraud S., Murat A., Niccoli-Sire P., Richard S., Rohmer V., Sadoul J.L., Strompf L., Schlumberger M., Bertagna X., Plouin P.F., Jeunemaitre X., Gimenez-Roqueplo A.P. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2005, 23:8812-8818.
4. Amar L., Baudin E., Burnichon N., Peyrard S., Silvera S., Bertherat J., Bertagna X., Schlumberger M., Jeunemaitre X., Gimenez-Roqueplo A.P., Plouin P.F. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J. Clin. Endocrinol. Metab. 2007, 92:3822-3828.
5. Anastasiou D., Poulogiannis G., Asara J.M., Boxer M.B., Jiang J.K., Shen M., Bellinger G., Sasaki A.T., Locasale J.W., Auld D.S., Thomas C.J., Vander Heiden M.G., Cantley L.C. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
6. Astuti D., Latif F., Dallol A., Dahia P.L., Douglas F., George E., Skoldberg F., Husebye E.S., Eng C., Maher E.R. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 2001, 69:49-54.
7. Bayley J.P., Devilee P., Taschner P.E. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med. Genet. 2005, 6:39.
8. Baysal B.E. Clinical and molecular progress in hereditary paraganglioma. J. Med. Genet. 2008, 45:689-694.
9. Baysal B.E., Ferrell R.E., Willett-Brozick J.E., Lawrence E.C., Myssiorek D., Bosch A., van der Mey A., Taschner P.E., Rubinstein W.S., Myers E.N., Richard C.W., Cornelisse C.J., Devilee P., Devlin B. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287:848-851.
10. Biasutto L., Sassi N., Mattarei A., Marotta E., Cattelan P., Toninello A., Garbisa S., Zoratti M., Paradisi C. Impact of mitochondriotropic quercetin derivatives on mitochondria. Biochim. Biophys. Acta 2010, 1797:189-196. (Epub 2009 Oct 1014). 10.1016/j.bbabio.2009.1010.1001.
11. Blank A., Schmitt A.M., Korpershoek E., van Nederveen F., Rudolph T., Weber N., Strebel R.T., de Krijger R., Komminoth P., Perren A. SDHB loss predicts malignancy in pheochromocytomas/sympathetic paragangliomas, but not through hypoxia signalling. Endocr. Relat. Cancer 2010, 17:919-928.
12. Boedeker C.C., Neumann H.P., Maier W., Bausch B., Schipper J., Ridder G.J. Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol. Head Neck Surg. 2007, 137:126-129.
13. Bourgeron T., Rustin P., Chretien D., Birch-Machin M., Bourgeois M., Viegas-Pequignot E., Munnich A., Rotig A. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat. Genet. 1995, 11:144-149.
14. Brusque A.M., Borba Rosa R., Schuck P.F., Dalcin K.B., Ribeiro C.A., Silva C.G., Wannmacher C.M., Dutra-Filho C.S., Wyse A.T., Briones P., Wajner M. Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem. Int. 2002, 40:593-601.
15. Burnichon N., Rohmer V., Amar L., Herman P., Leboulleux S., Darrouzet V., Niccoli P., Gaillard D., Chabrier G., Chabolle F., Coupier I., Thieblot P., Lecomte P., Bertherat J., Wion-Barbot N., Murat A., Venisse A., Plouin P.F., Jeunemaitre X., Gimenez-Roqueplo A.P. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J. Clin. Endocrinol. Metab. 2009, 94:2817-2827.
16. Burnichon N., Briere J.J., Libe R., Vescovo L., Riviere J., Tissier F., Jouanno E., Jeunemaitre X., Benit P., Tzagoloff A., Rustin P., Bertherat J., Favier J., Gimenez-Roqueplo A.P. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 2010, 19:3011-3020.
17. Cantor J.R., Sabatini D.M. Cancer cell metabolism: one hallmark, many faces. Cancer Discov. 2012, 2:881-898. (Epub 2012 Sep 1125). 10.1158/2159-8290.CD-1112-0345.
18. Cecchini G. Function and structure of complex II of the respiratory chain. Annu. Rev. Biochem. 2003, 72:77-109.
19. Cervera A.M., Apostolova N., Crespo F.L., Mata M., McCreath K.J. Cells silenced for SDHB expression display characteristic features of the tumor phenotype. Cancer Res. 2008, 68:4058-4067.
20. Chen Y.R., Chen C.L., Pfeiffer D.R., Zweier J.L. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J. Biol. Chem. 2007, 282:32640-32654.
21. Chen C.L., Chen J., Rawale S., Varadharaj S., Kaumaya P.P., Zweier J.L., Chen Y.R. Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium. J. Biol. Chem. 2008, 283:27991-28003.
22. Chen Z., Li Y., Zhang H., Huang P., Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010, 29:4362-4368.
23. Choksi K.B., Nuss J.E., Boylston W.H., Rabek J.P., Papaconstantinou J. Age-related increases in oxidatively damaged proteins of mouse kidney mitochondrial electron transport chain complexes. Free Radic. Biol. Med. 2007, 43:1423-1438.
24. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48:749-762.
25. Crimi M., Esposti M.D. Apoptosis-induced changes in mitochondrial lipids. Biochim. Biophys. Acta 2011, 1813:551-557.
26. Dahia P.L., Ross K.N., Wright M.E., Hayashida C.Y., Santagata S., Barontini M., Kung A.L., Sanso G., Powers J.F., Tischler A.S., Hodin R., Heitritter S., Moore F., Dluhy R., Sosa J.A., Ocal I.T., Benn D.E., Marsh D.J., Robinson B.G., Schneider K., Garber J., Arum S.M., Korbonits M., Grossman A., Pigny P., Toledo S.P., Nose V., Li C., Stiles C.D. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 2005, 1:72-80.
27. Dibrov E., Fu S., Lemire B.D. The Saccharomyces cerevisiae TCM62 gene encodes a chaperone necessary for the assembly of the mitochondrial succinate dehydrogenase (complex II). J. Biol. Chem. 1998, 273:32042-32048.
28. Dong L.F., Swettenham E., Eliasson J., Wang X.F., Gold M., Medunic Y., Stantic M., Low P., Prochazka L., Witting P.K., Turanek J., Akporiaye E.T., Ralph S.J., Neuzil J. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res. 2007, 67:11906-11913.
29. Dong L.F., Low P., Dyason J.C., Wang X.F., Prochazka L., Witting P.K., Freeman R., Swettenham E., Valis K., Liu J., Zobalova R., Turanek J., Spitz D.R., Domann F.E., Scheffler I.E., Ralph S.J., Neuzil J. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008, 27:4324-4335.
30. Dong L.F., Freeman R., Liu J., Zobalova R., Marin-Hernandez A., Stantic M., Rohlena J., Valis K., Rodriguez-Enriquez S., Butcher B., Goodwin J., Brunk U.T., Witting P.K., Moreno-Sanchez R., Scheffler I.E., Ralph S.J., Neuzil J. Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin. Cancer Res. 2009, 15:1593-1600.
31. Dong L.F., Jameson V.J., Tilly D., Cerny J., Mahdavian E., Marin-Hernandez A., Hernandez-Esquivel L., Rodriguez-Enriquez S., Stursa J., Witting P.K., Stantic B., Rohlena J., Truksa J., Kluckova K., Dyason J.C., Ledvina M., Salvatore B.A., Moreno-Sanchez R., Coster M.J., Ralph S.J., Smith R.A., Neuzil J. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II. J. Biol. Chem. 2011, 286:3717-3728.
32. Dong L.F., Jameson V.J., Tilly D., Prochazka L., Rohlena J., Valis K., Truksa J., Zobalova R., Mahdavian E., Kluckova K., Stantic M., Stursa J., Freeman R., Witting P.K., Norberg E., Goodwin J., Salvatore B.A., Novotna J., Turanek J., Ledvina M., Hozak P., Zhivotovsky B., Coster M.J., Ralph S.J., Smith R.A., Neuzil J. Mitochondrial targeting of alpha-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy. Free Radic. Biol. Med. 2011, 50:1546-1555.
33. Douwes Dekker P.B., Hogendoorn P.C., Kuipers-Dijkshoorn N., Prins F.A., van Duinen S.G., Taschner P.E., van der Mey A.G., Cornelisse C.J. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Pathol. 2003, 201:480-486.
34. Droese S., Bleier L., Brandt U. A common mechanism links differently acting complex II inhibitors to cardioprotection: modulation of mitochondrial reactive oxygen species production. Mol. Pharmacol. 2011, 79(5):814-822.
35. Feichtinger R.G., Zimmermann F.A., Mayr J.A., Neureiter D., Ratschek M., Jones N., Sperl W., Kofler B. Alterations of respiratory chain complexes in sporadic pheochromocytoma. Front. Biosci. (Elite Ed) 2011, 3:194-200.
36. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr. Neurol. 2008, 39:223-235.
37. Fruehauf J.P., Meyskens F.L. Reactive oxygen species: a breath of life or death?. Clin. Cancer Res. 2007, 13:789-794.
38. Gebert N., Gebert M., Oeljeklaus S., von der Malsburg K., Stroud D.A., Kulawiak B., Wirth C., Zahedi R.P., Dolezal P., Wiese S., Simon O., Schulze-Specking A., Truscott K.N., Sickmann A., Rehling P., Guiard B., Hunte C., Warscheid B., van der Laan M., Pfanner N., Wiedemann N. Dual function of Sdh3 in the respiratory chain and TIM22 protein translocase of the mitochondrial inner membrane. Mol. Cell 2011, 44:811-818.
39. Ghezzi D., Goffrini P., Uziel G., Horvath R., Klopstock T., Lochmuller H., D'Adamo P., Gasparini P., Strom T.M., Prokisch H., Invernizzi F., Ferrero I., Zeviani M. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat. Genet. 2009, 41:654-656.
40. Gill A.J. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology 2012, 44:285-292.
41. Gimenez-Roqueplo A.P., Favier J., Rustin P., Mourad J.J., Plouin P.F., Corvol P., Rotig A., Jeunemaitre X. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet. 2001, 69:1186-1197.
42. Gimenez-Roqueplo A.P., Favier J., Rustin P., Rieubland C., Crespin M., Nau V., Khau Van Kien P., Corvol P., Plouin P.F., Jeunemaitre X. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res. 2003, 63:5615-5621.
43. Gogvadze V., Zhivotovsky B., Orrenius S. The Warburg effect and mitochondrial stability in cancer cells. Mol. Aspects Med. 2010, 31:60-74.
44. Gonzalvez F., Schug Z.T., Houtkooper R.H., MacKenzie E.D., Brooks D.G., Wanders R.J., Petit P.X., Vaz F.M., Gottlieb E. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J. Cell Biol. 2008, 183:681-696.
45. Gottlieb E., Tomlinson I.P. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer 2005, 5:857-866.
46. Grimm S. Respiratory chain complex II as general sensor for apoptosis. Biochim. Biophys. Acta 2013, 1827:565-572.
47. Grimm S., Kachel V. Robotic high-throughput assay for isolating apoptosis-inducing genes. Biotechniques 2002, 32:670-677.
48. Grimm S., Leder P. An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes. J. Exp. Med. 1997, 185:1137-1142.
49. Guo J., Lemire B.D. The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide. J. Biol. Chem. 2003, 278:47629-47635.
50. Guo K., Searfoss G., Krolikowski D., Pagnoni M., Franks C., Clark K., Yu K.T., Jaye M., Ivashchenko Y. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ. 2001, 8:367-376.
51. Guzy R.D., Sharma B., Bell E., Chandel N.S., Schumacker P.T. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol. Cell. Biol. 2008, 28:718-731.
52. Habano W., Sugai T., Nakamura S., Uesugi N., Higuchi T., Terashima M., Horiuchi S. Reduced expression and loss of heterozygosity of the SDHD gene in colorectal and gastric cancer. Oncol. Rep. 2003, 10:1375-1380.
53. Hao H.X., Khalimonchuk O., Schraders M., Dephoure N., Bayley J.P., Kunst H., Devilee P., Cremers C.W., Schiffman J.D., Bentz B.G., Gygi S.P., Winge D.R., Kremer H., Rutter J. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009, 325:1139-1142.
54. Hervouet E., Cizkova A., Demont J., Vojtiskova A., Pecina P., Franssen-van Hal N.L., Keijer J., Simonnet H., Ivanek R., Kmoch S., Godinot C., Houstek J. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 2008, 29:1528-1537.
55. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707.
56. Huang J., Lemire B.D. Mutations in the C. elegans succinate dehydrogenase iron-sulfur subunit promote superoxide generation and premature aging. J. Mol. Biol. 2009, 387:559-569.
57. 2+ influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction. Cell Death Differ. 2014, (in press).
58. Ishii T., Yasuda K., Akatsuka A., Hino O., Hartman P.S., Ishii N. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res. 2005, 65:203-209.
59. Janeway K.A., Kim S.Y., Lodish M., Nose V., Rustin P., Gaal J., Dahia P.L., Liegl B., Ball E.R., Raygada M., Lai A.H., Kelly L., Hornick J.L., O'Sullivan M., de Krijger R.R., Dinjens W.N., Demetri G.D., Antonescu C.R., Fletcher J.A., Helman L., Stratakis C.A. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:314-318.
60. Kawada M., Momose I., Someno T., Tsujiuchi G., Ikeda D. New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells. J. Antibiot. (Tokyo) 2009, 62:243-246.
61. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
62. Kim H.J., Khalimonchuk O., Smith P.M., Winge D.R. Structure, function, and assembly of heme centers in mitochondrial respiratory complexes. Biochim. Biophys. Acta 2012, 1823:1604-1616.
63. Klanner C., Neupert W., Langer T. The chaperonin-related protein Tcm62p ensures mitochondrial gene expression under heat stress. FEBS Lett. 2000, 470:365-369.
64. Lagadic-Gossmann D., Huc L., Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 2004, 11:953-961.
65. Lee S., Nakamura E., Yang H., Wei W., Linggi M.S., Sajan M.P., Farese R.V., Freeman R.S., Carter B.D., Kaelin W.G., Schlisio S. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 2005, 8:155-167.
66. Lemarie A., Grimm S. Mutations in the heme b-binding residue of SDHC inhibit assembly of respiratory chain complex II in mammalian cells. Mitochondrion 2009, 9:254-260.
67. Lemarie A., Huc L., Pazarentzos E., Mahul-Mellier A.L., Grimm S. Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction. Cell Death Differ. 2011, 18:338-349.
68. Lenaz G., Genova M.L. Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject. Antioxid. Redox Signal. 2010, 12:961-1008.
69. Maklashina E., Cecchini G. The quinone-binding and catalytic site of complex II. Biochim. Biophys. Acta 2010, 1797:1877-1882.
70. McLaughlin B.A., Nelson D., Silver I.A., Erecinska M., Chesselet M.F. Methylmalonate toxicity in primary neuronal cultures. Neuroscience 1998, 86:279-290.
71. McWhinney S.R., Pasini B., Stratakis C.A. Familial gastrointestinal stromal tumors and germ-line mutations. N. Engl. J. Med. 2007, 357:1054-1056.
72. Miyadera H., Shiomi K., Ui H., Yamaguchi Y., Masuma R., Tomoda H., Miyoshi H., Osanai A., Kita K., Omura S. Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase). Proc. Natl. Acad. Sci. U. S. A. 2003, 100:473-477.
73. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
74. Murphy M.P., Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 2007, 47:629-656.
75. Nakamura K., Yamaki M., Sarada M., Nakayama S., Vibat C.R., Gennis R.B., Nakayashiki T., Inokuchi H., Kojima S., Kita K. Two hydrophobic subunits are essential for the heme b ligation and functional assembly of complex II (succinate-ubiquinone oxidoreductase) from Escherichia coli. J. Biol. Chem. 1996, 271:521-527.
76. Neumann H.P., Pawlu C., Peczkowska M., Bausch B., McWhinney S.R., Muresan M., Buchta M., Franke G., Klisch J., Bley T.A., Hoegerle S., Boedeker C.C., Opocher G., Schipper J., Januszewicz A., Eng C. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 292:943-951.
77. Neuzil J., Weber T., Gellert N., Weber C. Selective cancer cell killing by alpha-tocopheryl succinate. Br. J. Cancer 2001, 84:87-89.
78. Neuzil J., Dyason J.C., Freeman R., Dong L.F., Prochazka L., Wang X.F., Scheffler I., Ralph S.J. Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J. Bioenerg. Biomembr. 2007, 39:65-72.
79. Neuzil J., Dong L.F., Rohlena J., Truksa J., Ralph S.J. Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion 2013, 13:199-208.
80. Niemann S., Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 2000, 26:268-270.
81. Nijtmans L.G., de Jong L., Artal Sanz M., Coates P.J., Berden J.A., Back J.W., Muijsers A.O., van der Spek H., Grivell L.A. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000, 19:2444-2451.
82. Nijtmans L.G., Artal S.M., Grivell L.A., Coates P.J. The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol. Life Sci. 2002, 59:143-155.
83. Omura S., Tomoda H., Kimura K., Zhen D.Z., Kumagai H., Igarashi K., Imamura N., Takahashi Y., Tanaka Y., Iwai Y. Atpenins, new antifungal antibiotics produced by Penicillium sp. Production, isolation, physico-chemical and biological properties. J. Antibiot. (Tokyo) 1988, 41:1769-1773.
84. Oostveen F.G., Au H.C., Meijer P.J., Scheffler I.E. A Chinese hamster mutant cell line with a defect in the integral membrane protein CII-3 of complex II of the mitochondrial electron transport chain. J. Biol. Chem. 1995, 270:26104-26108.
85. Oshino K., Kumagai H., Tomoda H., Omura S. Mechanism of action of atpenin B on Raji cells. J. Antibiot. (Tokyo) 1990, 43:1064-1068.
86. Oyedotun K.S., Sit C.S., Lemire B.D. The Saccharomyces cerevisiae succinate dehydrogenase does not require heme for ubiquinone reduction. Biochim. Biophys. Acta 2007, 1767:1436-1445. (Epub 2007 Sep 1429).
87. Pang Z., Geddes J.W. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 1997, 17:3064-3073.
88. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187-197.
89. Peczkowska M., Cascon A., Prejbisz A., Kubaszek A., Cwikla B.J., Furmanek M., Erlic Z., Eng C., Januszewicz A., Neumann H.P. Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:111-115.
90. Prochazka L., Dong L.F., Valis K., Freeman R., Ralph S.J., Turanek J., Neuzil J. Alpha-tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels. Apoptosis 2010, 15:782-794.
91. Putignani L., Raffa S., Pescosolido R., Aimati L., Signore F., Torrisi M.R., Grammatico P. Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria. Breast Cancer Res. Treat. 2008, 110:439-452.
92. Quinlan C.L., Orr A.L., Perevoshchikova I.V., Treberg J.R., Ackrell B.A., Brand M.D. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J. Biol. Chem. 2012, 287:27255-27264.
93. Ralph S.J., Moreno-Sanchez R., Neuzil J., Rodriguez-Enriquez S. Inhibitors of succinate: quinone reductase/complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death. Pharm. Res. 2011, 28:2695-2730.
94. Requejo R., Hurd T.R., Costa N.J., Murphy M.P. Cysteine residues exposed on protein surfaces are the dominant intramitochondrial thiol and may protect against oxidative damage. FEBS J. 2010, 277:1465-1480.
95. Ricci J.E., Gottlieb R.A., Green D.R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 2003, 160:65-75. (Epub 2003 Jan 2006).
96. Ricketts C., Woodward E.R., Killick P., Morris M.R., Astuti D., Latif F., Maher E.R. Germline SDHB mutations and familial renal cell carcinoma. J. Natl. Cancer Inst. 2008, 100:1260-1262.
97. Rikka S., Quinsay M.N., Thomas R.L., Kubli D.A., Zhang X., Murphy A.N., Gustafsson A.B. Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ. 2011, 18:721-731.
98. Rohlena J., Dong L.F., Kluckova K., Zobalova R., Goodwin J., Tilly D., Stursa J., Pecinova A., Philimonenko A., Hozak P., Banerjee J., Ledvina M., Sen C.K., Houstek J., Coster M.J., Neuzil J. Mitochondrially targeted alpha-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing. Antioxid. Redox Signal. 2011, 15:2923-2935.
99. Rohlena J., Dong L.F., Ralph S.J., Neuzil J. Anticancer drugs targeting the mitochondrial electron transport chain. Antioxid. Redox Signal. 2011, 15:2951-2974.
100. Rutter J., Winge D.R., Schiffman J.D. Succinate dehydrogenase - assembly, regulation and role in human disease. Mitochondrion 2010, 10:393-401.
101. Schimke R.N., Collins D.L., Stolle C.A. Paraganglioma, neuroblastoma, and a SDHB mutation: resolution of a 30-year-old mystery. Am. J. Med. Genet. A 2010, 152a:1531-1535.
102. Schlisio S., Kenchappa R.S., Vredeveld L.C., George R.E., Stewart R., Greulich H., Shahriari K., Nguyen N.V., Pigny P., Dahia P.L., Pomeroy S.L., Maris J.M., Look A.T., Meyerson M., Peeper D.S., Carter B.D., Kaelin W.G. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 2008, 22:884-893.
103. Schwall C.T., Greenwood V.L., Alder N.N. The stability and activity of respiratory complex II is cardiolipin-dependent. Biochim. Biophys. Acta 2012, 1817:1588-1596.
104. Sciacovelli M., Guzzo G., Morello V., Frezza C., Zheng L., Nannini N., Calabrese F., Laudiero G., Esposito F., Landriscina M., Defilippi P., Bernardi P., Rasola A. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab. 2013, 17:988-999. (910.1016/j.cmet.2013.1004.1019).
105. Semenza G.L., Jiang B.H., Leung S.W., Passantino R., Concordet J.P., Maire P., Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 1996, 271:32529-32537.
106. Senoo-Matsuda N., Yasuda K., Tsuda M., Ohkubo T., Yoshimura S., Nakazawa H., Hartman P.S., Ishii N. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 2001, 276:41553-41558.
107. , oxidative stress, and genomic instability. Cancer Res. 2006, 66:7615-7620.
108. Sun F., Huo X., Zhai Y., Wang A., Xu J., Su D., Bartlam M., Rao Z. Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 2005, 121:1043-1057.
109. Szeto S.S., Reinke S.N., Sykes B.D., Lemire B.D. Ubiquinone-binding site mutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate. J. Biol. Chem. 2007, 282:27518-27526.
110. Tran Q.M., Rothery R.A., Maklashina E., Cecchini G., Weiner J.H. The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b. J. Biol. Chem. 2006, 281:32310-32317.
111. Trnka J., Blaikie F.H., Smith R.A., Murphy M.P. A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. Free Radic. Biol. Med. 2008, 44:1406-1419.
112. Valis K., Prochazka L., Boura E., Chladova J., Obsil T., Rohlena J., Truksa J., Dong L.F., Ralph S.J., Neuzil J. Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner. Cancer Res. 2011, 71:946-954.
113. van Nederveen F.H., Gaal J., Favier J., Korpershoek E., Oldenburg R.A., de Bruyn E.M., Sleddens H.F., Derkx P., Riviere J., Dannenberg H., Petri B.J., Komminoth P., Pacak K., Hop W.C., Pollard P.J., Mannelli M., Bayley J.P., Perren A., Niemann S., Verhofstad A.A., de Bruine A.P., Maher E.R., Tissier F., Meatchi T., Badoual C., Bertherat J., Amar L., Alataki D., Van Marck E., Ferrau F., Francois J., de Herder W.W., Peeters M.P., van Linge A., Lenders J.W., Gimenez-Roqueplo A.P., de Krijger R.R., Dinjens W.N. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009, 10:764-771.
114. Vander Heiden M.G., Choy J.S., VanderWeele D.J., Brace J.L., Harris M.H., Bauer D.E., Prange B., Kron S.J., Thompson C.B., Rudin C.M. Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism. J. Biol. Chem. 2002, 277:44870-44876.
115. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
116. Waldmann J., Langer P., Habbe N., Fendrich V., Ramaswamy A., Rothmund M., Bartsch D.K., Slater E.P. Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas. Endocrine 2009, 35:347-355.
117. Wallace K.B., Starkov A.A. Mitochondrial targets of drug toxicity. Annu. Rev. Pharmacol. Toxicol. 2000, 40:353-388.
118. Weber T., Dalen H., Andera L., Negre-Salvayre A., Auge N., Sticha M., Lloret A., Terman A., Witting P.K., Higuchi M., Plasilova M., Zivny J., Gellert N., Weber C., Neuzil J. Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry (Mosc) 2003, 42:4277-4291.
119. Wojtovich A.P., Brookes P.S. The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial KATP channels. Basic Res. Cardiol. 2009, 104:121-129.
120. Yankovskaya V., Horsefield R., Tornroth S., Luna-Chavez C., Miyoshi H., Leger C., Byrne B., Cecchini G., Iwata S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 2003, 299:700-704.
121. Zhang Y., Marcillat O., Giulivi C., Ernster L., Davies K.J. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 1990, 265:16330-16336.
122. Zhao Z., Rothery R.A., Weiner J.H. Effects of site-directed mutations in Escherichia coli succinate dehydrogenase on the enzyme activity and production of superoxide radicals. Biochem. Cell Biol. 2006, 84:1013-1021.